FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945403311> ?p ?o ?g. }

• W2945403311 endingPage "1149" @default.
• W2945403311 startingPage "1137" @default.
• W2945403311 abstract "Abstract Objective γ‐Aminobutyric acid type A ( GABA A ) receptor subunit gene mutations are significant causes of epilepsy, which are often accompanied by various neuropsychiatric comorbidities, but the underlying mechanisms are unclear. It has been suggested that the comorbidities are caused by seizures, as the comorbidities often present in severe epilepsy syndromes. However, findings from both humans and animal models argue against this conclusion. Mutations in the GABA A receptor γ2 subunit gene GABRG 2 have been associated with anxiety alone or with severe epilepsy syndromes and comorbid anxiety, suggesting that a core molecular defect gives rise to the phenotypic spectrum. Here, we determined the pathophysiology of comorbid anxiety in GABRG 2 loss‐of‐function epilepsy syndromes, identified the central nucleus of the amygdala (CeA) as a primary site for epilepsy comorbid anxiety, and demonstrated a potential rescue of comorbid anxiety via neuromodulation of CeA neurons. Methods We used brain slice recordings, subcellular fractionation with Western blot, immunohistochemistry, confocal microscopy, and a battery of behavior tests in combination with a chemogenetic approach to characterize anxiety and its underlying mechanisms in a Gabrg2 +/Q390X knockin mouse and a Gabrg2 +/− knockout mouse, each associated with a different epilepsy syndrome. Results We found that impaired GABA ergic neurotransmission in CeA underlies anxiety in epilepsy, which is due to reduced GABA A receptor subunit expression resulting from the mutations. Impaired GABA A receptor expression reduced GABA ergic neurotransmission in CeA, but not in basolateral amygdala. Activation or inactivation of inhibitory neurons using a chemogenetic approach in CeA alone modulated anxietylike behaviors. Similarly, pharmacological enhancement of GABA ergic signaling via γ2 subunit‐containing receptors relieved the anxiety. Significance Together, these data demonstrate the molecular basis for a comorbidity of epilepsy, anxiety, and suggest that impaired GABA A receptor function in CeA due to a loss‐of‐function mutation could at least contribute to anxiety. Modulation of CeA neurons could cause or suppress anxiety, suggesting a potential use of CeA neurons as therapeutic targets for treatment of anxiety in addition to traditional pharmacological approaches." @default.
• W2945403311 created "2019-05-29" @default.
• W2945403311 creator A5000567158 @default.
• W2945403311 creator A5017109968 @default.
• W2945403311 creator A5019861536 @default.
• W2945403311 creator A5036068069 @default.
• W2945403311 creator A5044198884 @default.
• W2945403311 creator A5060718314 @default.
• W2945403311 creator A5062893593 @default.
• W2945403311 creator A5064566639 @default.
• W2945403311 date "2019-05-14" @default.
• W2945403311 modified "2023-10-16" @default.
• W2945403311 title "Molecular basis for and chemogenetic modulation of comorbidities in <i><scp>GABRG</scp>2</i>‐deficient epilepsies" @default.
• W2945403311 cites W1489737221 @default.
• W2945403311 cites W1538241732 @default.
• W2945403311 cites W1602497443 @default.
• W2945403311 cites W1604789895 @default.
• W2945403311 cites W1879074807 @default.
• W2945403311 cites W1966403223 @default.
• W2945403311 cites W1987472752 @default.
• W2945403311 cites W1989982790 @default.
• W2945403311 cites W1992639113 @default.
• W2945403311 cites W2003870213 @default.
• W2945403311 cites W2003912284 @default.
• W2945403311 cites W2008991090 @default.
• W2945403311 cites W2038777226 @default.
• W2945403311 cites W2047801483 @default.
• W2945403311 cites W2049678062 @default.
• W2945403311 cites W2050659319 @default.
• W2945403311 cites W2052754782 @default.
• W2945403311 cites W2057114717 @default.
• W2945403311 cites W2059423271 @default.
• W2945403311 cites W2075336613 @default.
• W2945403311 cites W2095166722 @default.
• W2945403311 cites W2104460069 @default.
• W2945403311 cites W2114992052 @default.
• W2945403311 cites W2121379737 @default.
• W2945403311 cites W2122817080 @default.
• W2945403311 cites W2133458388 @default.
• W2945403311 cites W2142152671 @default.
• W2945403311 cites W2155824202 @default.
• W2945403311 cites W2156257459 @default.
• W2945403311 cites W2203568037 @default.
• W2945403311 cites W2245596495 @default.
• W2945403311 cites W2427840519 @default.
• W2945403311 cites W2473248658 @default.
• W2945403311 cites W2474614729 @default.
• W2945403311 cites W2512833929 @default.
• W2945403311 cites W2556544290 @default.
• W2945403311 cites W2622537179 @default.
• W2945403311 cites W2762344252 @default.
• W2945403311 cites W2763680364 @default.
• W2945403311 cites W2770712639 @default.
• W2945403311 cites W2783334841 @default.
• W2945403311 cites W2783529179 @default.
• W2945403311 cites W2791163268 @default.
• W2945403311 doi "https://doi.org/10.1111/epi.15160" @default.
• W2945403311 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6880653" @default.
• W2945403311 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31087664" @default.
• W2945403311 hasPublicationYear "2019" @default.
• W2945403311 type Work @default.
• W2945403311 sameAs 2945403311 @default.
• W2945403311 citedByCount "7" @default.
• W2945403311 countsByYear W29454033112020 @default.
• W2945403311 countsByYear W29454033112021 @default.
• W2945403311 countsByYear W29454033112022 @default.
• W2945403311 countsByYear W29454033112023 @default.
• W2945403311 crossrefType "journal-article" @default.
• W2945403311 hasAuthorship W2945403311A5000567158 @default.
• W2945403311 hasAuthorship W2945403311A5017109968 @default.
• W2945403311 hasAuthorship W2945403311A5019861536 @default.
• W2945403311 hasAuthorship W2945403311A5036068069 @default.
• W2945403311 hasAuthorship W2945403311A5044198884 @default.
• W2945403311 hasAuthorship W2945403311A5060718314 @default.
• W2945403311 hasAuthorship W2945403311A5062893593 @default.
• W2945403311 hasAuthorship W2945403311A5064566639 @default.
• W2945403311 hasBestOaLocation W29454033112 @default.
• W2945403311 hasConcept C118552586 @default.
• W2945403311 hasConcept C126322002 @default.
• W2945403311 hasConcept C15744967 @default.
• W2945403311 hasConcept C168258287 @default.
• W2945403311 hasConcept C169760540 @default.
• W2945403311 hasConcept C170493617 @default.
• W2945403311 hasConcept C200170125 @default.
• W2945403311 hasConcept C2777426569 @default.
• W2945403311 hasConcept C2778186239 @default.
• W2945403311 hasConcept C2778734009 @default.
• W2945403311 hasConcept C2779144063 @default.
• W2945403311 hasConcept C2780451725 @default.
• W2945403311 hasConcept C558461103 @default.
• W2945403311 hasConcept C71924100 @default.
• W2945403311 hasConcept C86803240 @default.
• W2945403311 hasConceptScore W2945403311C118552586 @default.
• W2945403311 hasConceptScore W2945403311C126322002 @default.
• W2945403311 hasConceptScore W2945403311C15744967 @default.
• W2945403311 hasConceptScore W2945403311C168258287 @default.
• W2945403311 hasConceptScore W2945403311C169760540 @default.
• W2945403311 hasConceptScore W2945403311C170493617 @default.

• next